Bio-Rad Laboratories (BIO) Hits New Lifetime High

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Bio-Rad Laboratories ( BIO) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Bio-Rad Laboratories as such a stock due to the following factors:

  • BIO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $17.1 million.
  • BIO has traded 8,852 shares today.
  • BIO is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in BIO with the Ticky from Trade-Ideas. See the FREE profile for BIO NOW at Trade-Ideas

More details on BIO:

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. BIO has a PE ratio of 44.2. Currently there is 1 analyst that rates Bio-Rad Laboratories a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for Bio-Rad Laboratories has been 170,700 shares per day over the past 30 days. Bio-Rad has a market cap of $3.2 billion and is part of the health care sector and health services industry. The stock has a beta of 1.09 and a short float of 5.8% with 9.58 days to cover. Shares are up 11.9% year-to-date as of the close of trading on Monday.

If you liked this article you might like

Stocks Mixed Again as Dow Declines but Nasdaq Remains on Track for Record Close

Stocks Turn Positive, Nasdaq Trades Above Record Closing High

Biotech Premarket Movers: ILMN, NSTG, KITE

Bio-Rad Laboratories (BIO) Hits New Lifetime High Today

Strong And Under The Radar: Bio-Rad Laboratories (BIO)